As the SOS study only included participants with obesity, we aimed to test our hypothesis at the general population level and therefore measured plasma levels of adiponectin, leptin, and resistin in 88 pre-symptomatic patients before symptom onset of RA and 88 matched controls from the Medical Biobank of Northern Sweden. The gene discussed is ADIPOQ; the disease is obesity disorder.